CD24 in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis: Targeting Redundancy for Immunotherapy?

Publisher： Bentham Science Publishers

E-ISSN： 1875-631x|1|2|173-176

ISSN： 1573-3955

Source： Current Immunology Reviews, Vol.1, Iss.2, 2005-06, pp. : 173-176

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Escalating Immunotherapy of Multiple Sclerosis

By  

European Neurology, Vol. 42, Iss. 3, 1999-10 ,pp. : 121-127

Karger

Access to resources Recommend Favorite

Multiple Sclerosis after Allergen-Specific Immunotherapy and Influenza Vaccination

By  

European Neurology, Vol. 50, Iss. 4, 2003-11 ,pp. : 248-249

Karger

Access to resources Recommend Favorite

Autoimmune Hepatitis with Multiple Sclerosis and Graves Disease: Coincidence or Association

By  

Case Reports in Gastroenterology, Vol. 8, Iss. 3, 2014-10 ,pp. : 319-323

Karger

Access to resources Recommend Favorite

Smokers with Multiple Sclerosis Are More Likely to Report Comorbid Autoimmune Diseases

By  

Neuroepidemiology, Vol. 36, Iss. 2, 2011-02 ,pp. : 85-90

Karger

Access to resources Recommend Favorite

Escalating Immunotherapy with Mitoxantrone in Patients with Very Active Relapsing-Remitting or Progressive Multiple Sclerosis

By  

European Neurology, Vol. 43, Iss. 3, 2000-04 ,pp. : 186-187

Karger

Access to resources Recommend Favorite